돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 55237생성일: 2026년 10월 23일

Morpholine → N-[4-(5H-pyrrolo-[2,1-c][1,4]benzodiazepin10(11H)-ylcarbonyl)phenyl]4-morpholineacetamide

https://huagongshe.com/ko/reaction/55237

반응식

참여 물질

역할이름HCID투입량
반응물MorpholineHCID 8083—
반응물2(1H)-Pyrimidinone, tetrahydro-1,3-dimethyl-HCID 81646—
반응물2-chloro-N-[4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)ylcarbonyl)phenyl]acetamideHCID 21837075—
용매DichloromethaneHCID 6344—
생성물N-[4-(5H-pyrrolo-[2,1-c][1,4]benzodiazepin10(11H)-ylcarbonyl)phenyl]4-morpholineacetamideHCID 70059534106.8%

반응 단계

A stirred suspension of 0.19 g of 2-chloro-N-[4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)phenyl]acetamide in 1 ml of methylene chloride is added 0.44 g of morpholine followed by 1 ml of 1,3-di-methyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone and stirring continued for 20 hours. The methylene chloride is evaporated and the residue diluted with water. The resulting suspension is filtered and the precipitate washed with water. The brown solid is dissolved in 15 ml of ethyl acetate and washed with saturated NaHCO3, brine and dried with Na2SO4. The mixture is filtered and the filtrate evaporated in vacuo to give 0.23 g of a colorless gum which is stirred with ethyl acetate-hexanes to give 0.21 g of white solid. MS(CI): 431(M+H).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US05624923
출처 데이터셋uspto-grants-1997_04
ORD IDord-812d1eab6f704f1a9ac5904ff6a95181
출처 메모uspto-grants-1997_04